参考文献/References:
[1] 袁普卫,康武林,李小群,等.骨性关节炎发病机制及相关细胞因子的研究进展[J].中国矫形外科杂志,2016,24(11):1010-1015.
[2] 刘志队,史丽璞,桂银莉,等.补脾温肾宣痹汤对强直性脊柱炎(AS)患者疗效及生活质量的影响[J].数理医药学杂志,2017,30(8):1215-1216.
[3] 曾秋萍,戴琴香.温肾宣痹汤与物理因子治疗骨质增生腰痛51例小结[J].亚太传统医药,2008,4(7):55-56.
[4] 魏成建.诸方受运用温肾宣痹汤经验举隅[J].辽宁中医杂志,2006,33(6):744-745.
[5] ZHOU G W,LI R Q,XIA T W,et al.Utilizing network pharmacology to explore the underlying mechanism of cinnamomum cassia presl in treating osteoarthritis[J].International Journal of Clinical and Experimental Medicine,2019,12(12):13359-13369.
[6] XIA T W,HUAN D W,MAO G Q,et al.Utilizing network pharmacology to explore the underlying mechanism of cinnamomum cassia presl in treating osteoarthritis[J].International Journal of Clinical and Experimental Medicine,2020,13(10):7427-7436.
[7] XIA T W,GAO R Z,ZHOU G W,et al.Trans-cinnamaldehyde inhibits IL-1 β-stimulated inflammation in chondrocytes by suppressing NF-κB and p38-JNK pathways and exerts chondrocyte protective effects in a rat model of osteoarthritis[J].BioMed Research International,2019:4039472.
[8] 黄聪琳,李晓东,谢兴文,等.膝骨关节炎生物标记物研究进展[J].中国中医骨伤科杂志,2019,27(4):81-84.
[9] 周圆家,邹磊,董金波,等.miR-146a/27a在SD大鼠OA软骨、滑膜组织中的表达及意义[J].安徽医科大学学报,2015,50(3):275-279.
[10] 王欢,唐学章,丁海涛,等.桂皮醛对miRNA-146a干扰的骨关节炎滑膜炎性反应影响的实验研究[J].世界中医药,2017,12(10):2408-2413.
[11] FUNAHASHI Y.MiR-146a targeted to splenic macrophages prevents sepsis-induced multiple organ injury[J].Lab Invest,2019,99(8):1130-1142.
[12] WANG J.MiR-146a mimic attenuates murine allergic rhinitis by downregulating TLR4/TRAF6/NF-κB pathway[J].Immunotherapy,2019,11(13):1095-1105.
[13] ZHANG J.MiR-146a promotes oligodendrocyte progenitor cell differentiation and enhances remyelination in a model of experimental autoimmune encephalomyelitis[J].Neurobiology of Disease,2019,125:154-162.
[14] LI D,DUAN M Y,FENG Y,et al.MiR-146a modulates macrophage polarization in systemic juvenile idiopathic arthritis by targeting INHBA[J].Mol Immunol,2016,77:205-212.